Drug intelligence / Profile preview

potassium phosphate + sodium phosphate

Development stage
Phase 1
Lead developer
University of Chicago
Modality
Small Molecules
Administration
Oral
01

Overview

Potassium phosphate + sodium phosphate (commonly referred to as neutral phosphate) is an oral phosphorus supplement and urinary modifier. It is a fixed-dose combination of monobasic and dibasic sodium and potassium phosphate salts formulated to maintain a neutral pH of approximately 7.0. The drug is primarily indicated for the treatment and prevention of hypophosphatemia and to prevent the recurrence of calcium-containing kidney stones (such as calcium oxalate and calcium phosphate stones). By increasing serum phosphate levels, it downregulates the synthesis of active vitamin D (1,25-dihydroxyvitamin D), which subsequently decreases intestinal calcium absorption and urinary calcium excretion. Additionally, it increases the urinary excretion of pyrophosphate, a potent natural inhibitor of calcium stone crystallization. The University of Chicago has conducted clinical trials evaluating low-dose neutral phosphate supplementation specifically for patients with recurrent calcium oxalate kidney stones and hypophosphatemia.

Brand names
K-Phos NeutralNeutra-PhosPhos-NaKPhospha 250 NeutralPhospha250 NeutralPhospha-250 NeutralPhospho-Trin 250 NeutralPhospho-Trin250 NeutralPhospho-Trin-250 NeutralUro-KP-NeutralVirt-Phos 250 NeutralVirt-Phos250 NeutralVirt-Phos-250 NeutralWes-Phos 250 NeutralWes-Phos250 NeutralWes-Phos-250 Neutral
Other names
neutral orthophosphateneutral phosphateorthophosphatepotassium acid phosphate and sodium acid phosphatepotassium phosphate and sodium acid phosphatepotassium phosphate and sodium phosphatesodium potassium phosphate

Beyond the preview

Go deeper on potassium phosphate + sodium phosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium phosphate + sodium phosphate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call